Followers | 12 |
Posts | 471 |
Boards Moderated | 0 |
Alias Born | 06/20/2020 |
Thursday, May 27, 2021 6:46:23 AM
In any case, to get a better idea of the degree to which IPIX's was involved in the paper Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture that appeared in the journal viruses, you can look at the “Author Contributions” section. In that section, “W.K.W.” stands for Warren K. Weston, an IPIX consultant and “J.A.H.” stands for Jane A. Harness, an IPIX employee.
Conceptualization, A.B., A.N., T.L.C., W.K.W., and J.A.H.; Methodology, A.B., W.K.W., J.A.H.; A.B., K.R., N.B., F.A., and T.L.C. conducted experiments; Visualization, Formal analysis, Data curation, A.B., A.N., W.K.W., T.L.C., and J.A.H.; Writing—original draft preparation, A.B., A.N., W.K.W., and J.A.H.; Writing—review and editing, A.B., A.N., W.K.W., and J.A.H.; Project administration, A.N., W.K.W., and J.A.H.; Funding acquisition, A.N., W.K.W., and J.A.H. All authors have read and agreed to the published version of the manuscript.
An IPIX employee or consultant is credited with the following:
Conceptualization
Methodology
Visualization, Formal analysis, Data curation
Writing -- original draft preparation
Writing -- review and editing
Project administration
Funding acquisition
The only category IPIX did not participate in was "conducting experiments".
It's important to note that I don't dispute the results. I don't think IPIX influenced events other than putting out misleading PRs that gave the impression that the testing was being done in a black box. I think many readers of this board believed that brilacidin had been selected for testing and that IPIX had to wait to get the results (remember those posts about IPIX will only know when the RBL decided to give them info?).
It's also important to recognize that this information was not disclosed in the preprint. It's possible there were readers of this board and others interested in IPIX who read the preprint and assumed the peer-reviewed version was the same.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM